Abstract
Basically flavonoids are naturally occurring phenolic compounds that are distributed in plants. They contain wide range of biological activity and lot of research has been carried out on their potential role in treating diabetes and other diseases. Most importantly the flavonoids and their related natural compounds are known to encompass antidiabetic potential, demonstrated in various animal models. Such beneficial flavonoids are less utilized on account of its deprived solubility, decreased bioavailability; first pass metabolism and intestinal degradation. However, flavonoids are capable of improving, stabilizing and long sustaining the insulin secretion, human islets and pancreatic cell respectively. In this article we propose, remarkable antidiabetic activity of flavonoids as well as few approaches on nanoparticulate systems in diabetes induced animal models. The proposed nanoparticulate system of flavonoids is projected to improve the solubility, bioavailability, by passing the first pass metabolism and decreasing susceptibility to intestinal environment as compared to pure flavonoid isolates. Further, this hypothesis exemplifies to enhance the efficacy of flavonoids in a novel way of antidiabetic treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
